scholarly journals Genetic Variant on Chromosome 12p13 Does Not Show Association to Ischemic Stroke in 3 Swedish Case-Control Studies

Stroke ◽  
2011 ◽  
Vol 42 (1) ◽  
pp. 214-216 ◽  
Author(s):  
Sandra Olsson ◽  
Olle Melander ◽  
Katarina Jood ◽  
J. Gustav Smith ◽  
Håkan Lövkvist ◽  
...  
2010 ◽  
Vol 29 (6) ◽  
pp. 528-537 ◽  
Author(s):  
Sophie Domingues-Montanari ◽  
Israel Fernández-Cadenas ◽  
Alberto del Rio-Espinola ◽  
Natalia Corbeto ◽  
Tiago Krug ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-11 ◽  
Author(s):  
Gertrude Namale ◽  
Onesmus Kamacooko ◽  
Alison Kinengyere ◽  
Laetitia Yperzeele ◽  
Patrick Cras ◽  
...  

Introduction. In sub-Saharan Africa (SSA), there is a significant burden of ischemic stroke (IS) and hemorrhagic stroke (HS), although data on risk factors for each type are sparse. In this systematic review we attempt to characterize the risk factors. Methods. We systematically reviewed (PubMed, EMBASE, WHOLIS, Google Scholar, Wiley online, and the Cochrane Central Register of Controlled Trials (CENTRAL)) case-control studies and case series from 1980 to 2016 that reported risk factors for IS and/or HS in SSA. For each risk factor we calculated random-effects pooled odds ratios (ORs) for case-control studies and pooled prevalence estimates for case series. Results. We identified 12 studies, including 4,387 stroke patients. Pooled analysis showed that patients who had diabetes (OR = 2.39; 95% CI: 1.14–5.03) and HIV (OR = 2.46 (95% CI: 1.59–3.81) were at a significantly greater risk of suffering from all stroke types. There were insufficient data to examine these factors by stroke type. Among case series, the pooled prevalence of hypertension was higher for HS than for IS (73.5% versus 62.8%), while diabetes mellitus (DM) and atrial fibrillation (AF) were more prevalent among IS compared to HS (15.9% versus 10.6% and 9.6% versus 2.3%, respectively). Conclusions. There remain too few data from SSA to reliably estimate the effect of various factors on the risk of IS and HS. Furthermore, the vast majority of cases were identified in hospital and so are unlikely to be representative of the totality of stroke cases in the community.


2016 ◽  
Vol 137 ◽  
pp. 17-25 ◽  
Author(s):  
Min Chen ◽  
Ben Yu Mao ◽  
Dan Wang ◽  
Xianglin Cheng ◽  
Chuan Xin Xu

2020 ◽  
Vol 120 (05) ◽  
pp. 815-822
Author(s):  
Artur Słomka ◽  
Mariusz Kowalewski ◽  
Ewa Żekanowska ◽  
Piotr Suwalski ◽  
Roberto Lorusso ◽  
...  

AbstractThe association between blood levels of protein Z (PZ) and risk of ischemic stroke remains poorly understood. We aimed to assess this potential relationship through a meta-analysis of case–control studies. PubMed, Scopus, Web of Science Core Collection, and the Cochrane Library were searched from April 1984 to April 2019. We selected case–control studies comparing PZ levels in adult patients with ischemic stroke and controls without ischemic stroke. Six case–control studies, with a total of 1,011 ischemic stroke patients and 1,128 controls, were included. Patients in the acute phase of ischemic stroke showed significantly higher levels of PZ compared with patients in the convalescent phase (standardized mean difference [SMD]: 0.289 mg/L; 95% confidence interval [CI]: 0.010, 0.569; p = 0.043). No significant differences in PZ levels were found between patients and controls in the acute phase (SMD: −0.059 mg/L; 95% CI: −0.570, 0.452; p = 0.821) or in the convalescent phase of ischemic stroke (SMD: −0.341 mg/L; 95% CI: −0.736, 0.055; p = 0.091). Subgroup analysis indicated that older patients (≥ 50 years old) had lower PZ levels than similarly aged controls. In contrast, when the study groups came from the United States and Australia or Europe no significant differences in PZ levels existed between patients and controls. No association between PZ and ischemic stroke was identified in this meta-analysis. The acute phase of ischemic stroke was associated with higher levels of PZ.


Sign in / Sign up

Export Citation Format

Share Document